Clinical Trials Browser

Phase 3 × Active not recruiting × Breast Cancer Metastatic × Clear all

NCT06612814 2024-09-25

PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Phase 3 Active not recruiting

Breast Cancer Metastatic